Difference between revisions of "Canadian Institutes of Health Research"
(unstub) |
(Big Pharma control) |
||
| Line 19: | Line 19: | ||
==Shaping psychological and behavioral response== | ==Shaping psychological and behavioral response== | ||
CIHR spent at least $500,000<ref>https://educationnewscanada.com/article/education/region/quebec/26/829640/universite-de-sherbrookeapril-23-2020-covid-19-stress-and-anxiety-very-present-in-quebec-and-canada-aggravated-by-misinformation.html</ref> "to undertake a cross-country comparative rapid research on the role of communication strategies and media discourse in shaping psychological and behavioral response to the [[COVID-19]] outbreak".<ref>http://ccouc.org/the-role-of-communication-strategies-and-media-discourse-in-shaping-psychological-and-behavioral</ref> | CIHR spent at least $500,000<ref>https://educationnewscanada.com/article/education/region/quebec/26/829640/universite-de-sherbrookeapril-23-2020-covid-19-stress-and-anxiety-very-present-in-quebec-and-canada-aggravated-by-misinformation.html</ref> "to undertake a cross-country comparative rapid research on the role of communication strategies and media discourse in shaping psychological and behavioral response to the [[COVID-19]] outbreak".<ref>http://ccouc.org/the-role-of-communication-strategies-and-media-discourse-in-shaping-psychological-and-behavioral</ref> | ||
| + | |||
| + | ==Big Pharma== | ||
| + | CIHR works with [[Big Pharma]] "partners and stakeholders".<ref>https://cihr-irsc.gc.ca/e/30162.html</ref> Some programs sponsored by [[GlaxoSmithKline]] is "managed and administered" by [[CIHR]]<ref>https://ca.gsk.com/en-ca/media/press-releases/gsk-announces-largest-private-financial-contribution-to-cihr-s-team-grants-initiative-addressing-threats-to-canadian-lung-health/</ref> | ||
| + | In [[2009]], a parliamentary committee wanted to know why a drug-company executive was appointed to the board of the "independent" public agency, complaining about the appointment of Dr. [[Bernard Prigent]], vice-president of [[Pfizer|Pfizer Canada]], to the governing council of the CIHR as a "potential conflict of interest." NDP parliamentarian [[Judy Wasylycia-Leis]] said in a statement that: | ||
| + | |||
| + | {{QB|Having the drug companies' executives deciding health research directions is like having the big bad wolf directing the three little pigs on how to build their homes, " <ref>https://www.queensu.ca/academia/forsdyke/peerrev13.htm</ref>}} | ||
| + | |||
| + | |||
{{SMWDocs}} | {{SMWDocs}} | ||
==References== | ==References== | ||
{{reflist}} | {{reflist}} | ||
Latest revision as of 09:32, 7 December 2023
 Canadian Institutes of Health Research  (National public health agency)     | |
|---|---|
 | |
| Formation | 7 June,2000 |
| Headquarters | Ottawa, Canada |
| Interests | COVID-19/Censorship |
| Sponsored by | GlaxoSmithKline |
| Funding "research on the role of communication strategies and media discourse in shaping psychological and behavioral response to the COVID-19 outbreak." | |
The Canadian Institutes of Health Research (CIHR) is the major federal agency responsible for funding health and medical research in Canada.
Contents
Official narrative
CIHR supports more than 13,000 researchers and trainees through grants, fellowships, scholarships, and other funding. CIHR was created by an Act of Parliament on June 7, 2000, bringing together existing government activities. CIHR's annual budget is approximately $1 billion. [1]
CIHR combined with the Social Sciences and Humanities Research Council and the Natural Sciences and Engineering Research Council forms the major source of federal government funding to post-secondary research.[2]
Shaping psychological and behavioral response
CIHR spent at least $500,000[3] "to undertake a cross-country comparative rapid research on the role of communication strategies and media discourse in shaping psychological and behavioral response to the COVID-19 outbreak".[4]
Big Pharma
CIHR works with Big Pharma "partners and stakeholders".[5] Some programs sponsored by GlaxoSmithKline is "managed and administered" by CIHR[6] In 2009, a parliamentary committee wanted to know why a drug-company executive was appointed to the board of the "independent" public agency, complaining about the appointment of Dr. Bernard Prigent, vice-president of Pfizer Canada, to the governing council of the CIHR as a "potential conflict of interest." NDP parliamentarian Judy Wasylycia-Leis said in a statement that:
Having the drug companies' executives deciding health research directions is like having the big bad wolf directing the three little pigs on how to build their homes, " [7]
Sponsor
| Event |
|---|
| GlaxoSmithKline |
References
- ↑ https://laws.justice.gc.ca/eng/acts/c-18.1/page-1.html
- ↑ https://www.nserc-crsng.gc.ca/InterAgency-Interorganismes/TAFA-AFTO/index_eng.asp
- ↑ https://educationnewscanada.com/article/education/region/quebec/26/829640/universite-de-sherbrookeapril-23-2020-covid-19-stress-and-anxiety-very-present-in-quebec-and-canada-aggravated-by-misinformation.html
- ↑ http://ccouc.org/the-role-of-communication-strategies-and-media-discourse-in-shaping-psychological-and-behavioral
- ↑ https://cihr-irsc.gc.ca/e/30162.html
- ↑ https://ca.gsk.com/en-ca/media/press-releases/gsk-announces-largest-private-financial-contribution-to-cihr-s-team-grants-initiative-addressing-threats-to-canadian-lung-health/
- ↑ https://www.queensu.ca/academia/forsdyke/peerrev13.htm
